What type of insulin can I start for a sliding scale regimen?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Rapid-Acting Insulin Analogs Are Preferred for Sliding Scale Insulin Regimens

For sliding scale insulin regimens, rapid-acting insulin analogs such as insulin aspart, lispro, or glulisine are the preferred options due to their quick onset of action and shorter duration, which better addresses post-meal hyperglycemia with lower risk of delayed hypoglycemia. 1

Sliding Scale Insulin Options

Preferred Options:

  • Rapid-acting insulin analogs:
    • Insulin aspart (Novolog, Fiasp)
    • Insulin lispro (Humalog)
    • Insulin glulisine (Apidra)

These insulins have:

  • Onset of action: 10-15 minutes
  • Peak effect: 1-2 hours
  • Duration: 3-4 hours

Alternative Option:

  • Regular (short-acting) insulin:
    • Human regular insulin (Humulin R, Novolin R)
    • Onset: 30-60 minutes
    • Peak: 2-3 hours
    • Duration: 5-8 hours

Implementation Guidelines

When implementing a sliding scale insulin regimen:

  1. Start with a standardized protocol:

    • Use a preprinted physician order form when available
    • Select appropriate scale based on insulin sensitivity
    • Example basic scale:
      • Blood glucose >150-200 mg/dL: 2 units
      • Blood glucose >200-250 mg/dL: 4 units
      • Blood glucose >250-300 mg/dL: 6 units
      • Blood glucose >300-350 mg/dL: 8 units
      • Blood glucose >350 mg/dL: 10 units and notify provider
  2. Timing considerations:

    • Administer before meals and at bedtime for patients who are eating
    • For NPO patients or continuous tube feeding, administer every 4-6 hours
  3. Documentation:

    • Record blood glucose results and insulin doses administered
    • Monitor for patterns requiring adjustment

Important Considerations and Pitfalls

Limitations of Sliding Scale Insulin:

  • Sliding scale insulin alone is reactive rather than preventive and has been associated with suboptimal glycemic control 1, 2, 3
  • Meta-analyses show that sliding scale insulin as monotherapy may increase hyperglycemic events 3

Avoid These Common Errors:

  • Using sliding scale insulin as the sole therapy for patients with established insulin requirements
  • Failing to adjust the sliding scale based on patterns of hyper/hypoglycemia
  • Not considering the patient's nutritional status when selecting insulin type

Best Practices:

  • Combine sliding scale insulin with basal insulin for better glycemic control
  • For patients on continuous tube feeding, consider NPH insulin every 4-6 hours instead of rapid-acting insulin 4
  • Regularly evaluate the effectiveness of the sliding scale and adjust as needed

Special Situations

  • Continuous enteral nutrition: NPH insulin every 4-6 hours may provide better glycemic control than rapid-acting insulin analogs 4
  • Critically ill patients: Consider IV regular insulin infusion rather than subcutaneous sliding scale 1
  • Older adults: May need lower doses and higher glycemic targets to avoid hypoglycemia 1

Remember that while sliding scale insulin can help manage acute hyperglycemia, it should ideally be part of a comprehensive insulin regimen that includes basal insulin coverage for most hospitalized patients with diabetes.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Evaluation of glycemic control using NPH insulin sliding scale versus insulin aspart sliding scale in continuously tube-fed patients.

Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.